Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 134.6B | 151.2B | 142.7B | 133.4B |
Cost of revenue | 100.4B | 108.5B | 98.7B | 92.4B |
Gross profit | 34.2B | 42.7B | 44.0B | 41.0B |
Operating expense | ||||
Research & development | 65.6M | 65.8M | 50.0M | 43.2M |
Selling general and admin | 33.1B | -40.0B | 30.4B | 29.5B |
Other operating expenses | 666.1M | 4.3B | 512.1M | 737.9M |
Operating income | 1.3B | 4.8B | 13.7B | 11.6B |
Non operating interest income | ||||
Income | 3.0B | 5.1B | 4.3B | 2.6B |
Expense | 10.8B | 12.5B | 9.8B | 9.4B |
Other income expense | — | — | — | — |
Pretax income | 5.8B | 1.8B | 15.0B | 9.0B |
Tax provision | 1.7B | 3.1B | 2.8B | 1.5B |
Net income | 4.1B | -1.3B | 12.1B | 7.5B |
Basic EPS | 2.4 | — | 12.1 | 7.4 |
Diluted EPS | 2.4 | — | 12.1 | 7.4 |
Basic average shares | 243.5M | — | 243.5M | 243.5M |
Diluted average shares | 243.5M | — | 243.5M | 243.5M |
EBITDA | 19.9B | 21.4B | 31.0B | 21.8B |
Net income from continuing op. | 4.1B | -1.3B | 13.4B | 5.6B |
Minority interests | -3.5B | -858.9M | -9.2B | -5.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |